VERTEX PHARMACEUTICALS INC (VRTX) Stock Institutional Trading Activity


VERTEX PHARMACEUTICALS INC (VRTX) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Tweedy, Browne Co All Funds (US), Parnassus Endeavor Fund, ARK Invest, and Torray Fund. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2023Parnassus Endeavor FundSell-239,515766$241,344
Q1 2023Renaissance Technologies LLCSell-849,0171,397,735$440,384
Q1 2023Sequoia Financial AdvisorsBuy1102,469$777,908
Q4 2022ARK InvestSell-35,248122,197$35,288,050
Q4 2022Renaissance Technologies LLCBuy107,8672,246,752$648,817
Q4 2022Sequoia Financial AdvisorsBuy1,3992,359$681,210
Q4 2022Parnassus Endeavor FundSell-21,686240,281$69,388,347
Q3 2022ARK InvestSell-208,077157,445$45,587
Q3 2022Sequoia Financial AdvisorsBuy20960$278
Q3 2022Renaissance Technologies LLCBuy377,7172,138,885$619,293
Q2 2022ARK InvestSell-56,253365,522$98,197
Q2 2022Sequoia Financial AdvisorsBuy940940$265
Q2 2022Parnassus Endeavor FundSell-309,518261,967$73,820
Q2 2022Renaissance Technologies LLCBuy53,8001,761,168$496,280
Q1 2022ARK InvestSell-507,016421,775$110,071
Q1 2022Parnassus Endeavor FundSell-47,953571,485$149,140
Q1 2022Renaissance Technologies LLCBuy80,5001,707,368$445,572
Q4 2021ARK InvestSell-780,960928,791$203,963
Q4 2021Renaissance Technologies LLCSell-264,6181,626,868$357,260
Q4 2021Hancock Classic ValueBuy2,9052,905$638
Q3 2021ARK InvestSell-64,3151,709,751$310,132
Q3 2021Renaissance Technologies LLCSell-385,7981,891,486$343,097
Q2 2021ARK InvestBuy55,0201,774,066$357,705
Q2 2021Parnassus Endeavor FundBuy619,438619,438$124,897
Q2 2021Renaissance Technologies LLCSell-123,0002,277,284$459,169
Q1 2021ARK InvestBuy902,8521,719,046$369,406
Q1 2021Renaissance Technologies LLCSell-1,175,6462,400,284$515,797
Q4 2020ARK InvestBuy718,842816,194$192,899
Q4 2020Renaissance Technologies LLCSell-1,631,0023,575,930$845,135
Q3 2020ARK InvestBuy97,35297,352$26,491

Frequently asked questions about VRTX activity

  • Which institutional owners are buying VRTX?

    Institutional owners buying VRTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in VRTX activity?

    "Buy" means an investor increased their reported position in VRTX compared to the prior reporting period. This reflects growing exposure to VERTEX PHARMACEUTICALS INC (VRTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in VRTX increasing?

    Institutional interest in VRTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.